Rheumatology Academy - Rheumatology Academy

Rheumatology Academy Hero

Where education meets excellence.
The latest rheumatology CME
& clinical updates you need.

Where education meets excellence.
The latest rheumatology CME & clinical updates you need.

Popular

Choosing a JAK Inhibitor for Rheumatoid Arthritis
Choosing a JAK Inhibitor for Rheumatoid Arthritis
Living Rheum
Choosing a JAK Inhibitor for Rheumatoid Arthritis
Roy Fleischmann, MD, MACR
- Roy Fleischmann, MD, MACR
Shared Decision-Making in Rheumatoid Arthritis Care
Shared Decision-Making in Rheumatoid Arthritis Care
Living Rheum
Shared Decision-Making in Rheumatoid Arthritis Care
Elena Myasoedova, MD, PhD
- Elena Myasoedova, MD, PhD
Beyond the Black Box: JAK Inhibitor Safety in RA
Beyond the Black Box: JAK Inhibitor Safety in RA
Living Rheum
Beyond the Black Box: JAK Inhibitor Safety in RA
Roy Fleischmann, MD, MACR
- Roy Fleischmann, MD, MACR
IFNα Is Associated with a Distinct Immune Endotype in Sjögren’s Disease
IFNα Is Associated with a Distinct Immune Endotype in Sjögren’s Disease
Living Rheum
IFNα Is Associated with a Distinct Immune Endotype in Sjögren’s Disease
The Potential Role of GLP-1s in Psoriatic Arthritis Management
The Potential Role of GLP-1s in Psoriatic Arthritis Management
Living Rheum
The Potential Role of GLP-1s in Psoriatic Arthritis Management
Philip Mease, MD, MACR
- Philip Mease, MD, MACR
How Delayed Diagnosis Can Affect Psoriatic Arthritis Patients
How Delayed Diagnosis Can Affect Psoriatic Arthritis Patients
Living Rheum
How Delayed Diagnosis Can Affect Psoriatic Arthritis Patients
Philip Mease, MD, MACR
- Philip Mease, MD, MACR
Targeting Celastrol Delivery to Inflamed Joints in Rheumatoid Arthritis
Targeting Celastrol Delivery to Inflamed Joints in Rheumatoid Arthritis
Living Rheum
Targeting Celastrol Delivery to Inflamed Joints in Rheumatoid Arthritis
How Obesity Influences Psoriatic Arthritis Risk and Outcomes
How Obesity Influences Psoriatic Arthritis Risk and Outcomes
Living Rheum
How Obesity Influences Psoriatic Arthritis Risk and Outcomes
Philip Mease, MD, MACR
- Philip Mease, MD, MACR

Medical News

Medical News
Checkpoint Inhibitor Rheumatic Toxicity in ERIN Registry
10/12/2026
Read more
Medical News
Telitacicept Outperforms Belimumab in 24-Week Active SLE Cohort
10/12/2026
Read more
Medical News
Low Proteinuria Linked to Fewer Events in Lupus Nephritis
10/06/2026
Read more
Medical News
15-PGDH Inhibition Promotes Cartilage Regeneration in OA
09/22/2026
Read more
Medical News
PFAS Exposure Linked to Rheumatoid Arthritis Risk
09/08/2026
Read more
Medical News
Medication Beliefs Linked to Adherence in Primary Sjögren Disease
09/04/2026
Read more
Medical News
Real-World Adult-Onset Still’s Disease Treatment Patterns
08/25/2026
Read more
Medical News
Single-Cell Study Links Sex Bias to Lupus-Related Immune Signals
08/24/2026
Read more